Table 4. Results SM ECG 2nd study group (M±SD).

Note: The statistical significance of inter-group differences in the t-test for dependent data (r1-2- between the 1st and 2nd stages), n-number of patients with arrhythmia and u 2 before and after by Wilcoxon, step by step.

Performance	After 48 h (1)	Within 1 month (2)	Growth rate,% (48 h-1 month)
Number of episodes of painful ischemia	3,38±2,95	0,86±1,62	-74,5 Р1-2= 0,0003
Number of episodes of silent ischemia	4,52±3,37	1,00±1,94	-77,8 Р1-2= 0,0002
The average duration of episodes of paroxysmal AF or TA min	15,36±4,22	3,17±2,25	-78,1 Р1-2= 0,0003
Ventricular premature beats, n	14	10	(1-2) (χ 2=20,9 р=0,00)
Supraventricular extrasystoles, n	8	4	(1-2) (χ 2=8,9 р=0,038)